BZI Xelr8 Holdings

- Management to Host Conference Call Today at 11:30 a.m. ET - DENVER, May 1 /PRNewswire-FirstCall/ -- XELR8 Holdings, Inc. (AMEX:BZI), a provider of liquid nutritional, functional foods, beverages and nutritional supplements, today announced its financial results for three months ended March 31, 2008. Financial and operational highlights for First Quarter of Fiscal 2008: -- Revenue increased 138% over prior year period to $1.6 million -- Gross profit was $1.2 million, an improvement of $0.6 million from one year ago -- Cash and cash equivalents were $2.5 million as of March 31, 2008 Total revenue for the first quarter ended March 31, 2008 was $1.6 million, an 82% increase compared to total revenue of $0.9 million for the fiscal year ended March 31, 2007. Gross profit grew to $1.2 million for the three months ended March 31, 2008, up 115% from $0.6 million in the prior year period. Gross margin in the quarter was 77%, an improvement of 12%, from 65% same quarter one year ago, due to increased sales of Bazi, which carries a higher gross margin compared to the legacy products. Net loss for the three months ended March 31, 2008, decreased 43% to $0.75 million, or $(0.05) per share, compared to a loss of $1.4 million, or $(0.13) per share, in the prior year. The Company's balance sheet continues to remain strong. As of March 31, 2008, cash and cash equivalents were approximately $2.5 million, which includes the proceeds from the $0.5 million financing completed during the quarter. Total shareholders' equity at the three months ended March 31, 2008 was $2.2 million and the Company remains debt free. Mr. John Pougnet, Chief Executive Officer of XELR8, commented, "I am pleased to report another record revenue quarter. Bazi continues to gain traction in the marketplace and showed major improvements partially due to our successful gathering of distributors in February at our national event as well as new sales aids and incentives offered. In the first quarter sales of Bazi rose approximately 138% from same period one year ago, to $1.4 million, or an increase of $0.8 million. Bazi represented 89% of the Company's total sales in the quarter versus 68% last year as customers favor the convenience and simplicity Bazi offers them." Mr. Pougnet continued, "The Company's main driver in the near-term is to continue to focus our efforts on growing sales of Bazi, which has shown tremendous growth in the last year, when it was first launched. As of March 31, 2008, we had 9,044 participants nationwide marketing Bazi, which was a 7.5% increase since our last tally of 8,416 participants which was as of February 29, 2008, partially due to the successful distributor convention in Las Vegas. Since then, we continue to remain in close contact with our distributors to obtain constant feedback as well as assist them in building their business as well. Recently we have offered new incentives and bonus features and conducted regional 'Go Diamond' events, in six major cities nationwide." "Our operating plan for 2008 remains on target and is focused on the continued growth and market penetration of Bazi by increasing the number of independent distributors and customers, which will help drive revenues and improve gross profit. Our cash burn has been diminished and the visibility to produce positive cash flow is vivid and within reach in the coming quarters," concluded Mr. Pougnet. Additionally, XELR8 and its liquid nutritional drink "Bazi" were featured on TheStreet.com's video segment entitled "Direct Selling is So Money" on Wednesday, April 30th. In the segment XELR8 distributor Emma Stith was interviewed along with Sandy Greenberg, distributor advocate and XELR8 founder. You can view the segment by cutting and pasting this url into your browser: http://www.thestreet.com/_yahoo/video/strategysession/10414473.html?cm_ven=YAH OO&cm_cat=FREE&cm_ite=NA#10414473 There will be a conference call today at 11:30 a.m. ET with the investment community, featuring John Pougnet, Chief Executive Officer of XELR8 Holdings, Inc. Interested parties may participate in the call by dialing 877-407-8293; international callers dial 201-689-8349. In addition, the replay of the conference call will be available approximately two hours after the call has ended. The replay can be accessed at: http://www.xelr8tools.com/Media/ConfCall050108.mp3 and will be archived for 30 days. About XELR8 Holdings, Inc. XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. These include the Company's Eat/Drink/Snack System; Peak Performance System; and its newest market entry, Bazi(TM), a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, one-ounce shot. XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott and Lawyer Milloy; professional football star Cadillac Williams; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. XELR8 products are only available through independent distributors located throughout the nation. For more information about XELR8, please visit http://www.xelr8.com/ or http://www.drinkbazi.com/. Forward-looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including prospects for XELR8's distribution network. Actual results may differ from those discussed in such forward-looking statements. These forward-looking statements include risks and uncertainties that include the Company's ability to attract and retain distributors; changes in demand for the Company's products; changes in the level of operating expenses; changes in general economic conditions that impact consumer behavior and spending; product supply; the availability, amount, and cost of capital for the Company; and the Company's use of such capital. More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2006 and all subsequent filings. Certain statements in this release regarding the Company's agreements are in accordance with the guidelines established by the Federal Trade Commission for endorsements in advertising. Contacts: Stephen D. Axelrod, CFA John Pougnet, CEO Alisa Steinberg (Media) XELR8 Holdings, Inc. Wolfe Axelrod Weinberger Assoc. LLC (303) 316-8577 (212) 370-4500 XELR8 HOLDINGS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) For the Quarters Ended March 31 December 31 2008 2007 ASSETS Current assets: Cash and cash equivalents $2,469,361 $2,245,858 Accounts receivable, net of allowance for doubtful accounts of $14,079 and $12,231, respectively 1,220 7,460 Inventory, net of allowance for obsolescence of $174,687 and $189,403, respectively 290,823 370,843 Prepaid expenses and other current assets 325,207 329,015 Total current assets 3,086,611 2,953,176 Intangible assets, net 17,652 17,959 Property and equipment, net 68,738 81,405 Total assets $3,173,001 $3,052,540 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $974,172 $832,697 Total Liabilities 974,172 832,697 Commitments and Contingencies SHAREHOLDERS' EQUITY (Note 2): Preferred stock, authorized 5,000,000 shares, $.001 par value, none issued or outstanding - - Common stock, authorized 50,000,000 shares, $.001 par value, 15,697,170 and 15,197,170 shares issued and outstanding respectively 15,697 15,197 Additional paid in capital 23,424,505 22,696,657 Accumulated (deficit) (21,241,373) (20,492,011) Total shareholders' equity 2,198,829 2,219,843 Total liabilities and shareholders' equity $3,173,001 $3,052,540 XELR8 HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Three Months Ended March 31, 2008 and 2007 For the Three For the Three Months Ended Months Ended March 31, 2008 March 31, 2007 Net sales $1,577,784 $869,075 Cost of goods sold 359,578 305,593 Gross profit 1,218,206 563,482 Operating expenses: Selling and marketing expenses 1,090,792 629,266 General and administrative expenses 868,886 849,521 Research and development expenses 424 614 Depreciation and amortization 11,844 11,779 Total operating expenses 1,971,946 1,491,180 Net (loss) from operations (753,740) (927,698) Other income (expense) Interest income 19,278 3,126 Other expense (13,770) - (Loss) on disposal of asset (1,130) Interest (expense) - (439,537) Total other income (expense) 4,378 (436,411) Net (loss) $(749,362) $(1,364,109) Net (loss) per common share Basic and diluted net (loss) per share $(0.05) $(0.13) Weighted average common shares outstanding, basic and diluted 15,334,533 10,753,350 XELR8 HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Three Months Ended March 31, 2008 and 2007 2008 2007 Cash flows from operating activities: Net income (loss) $(749,362) $(1,364,109) Adjustments to reconcile Depreciation and amortization 11,844 11,779 Stock and stock options issued for services 275,375 474,912 Expense related to anti-dilution of warrants 13,770 - Loss on asset disposal 1,130 - Interest expense and amortization related to bridge loan financing - 428,889 Change in allowance for doubtful accounts 1,848 2,368 Change in allowance for inventory obsolescence (14,716) 81,450 Change in allowance for product returns 10,092 30,866 Changes in assets and liabilities: Accounts receivable 4,392 (4,052) Inventory 94,736 (40,488) Other current assets 3,808 79,511 Accounts payable and accrued expenses 131,383 122,355 Net cash (used) by operating activities (215,700) (176,519) Cash flows from financing activities: Proceeds from bridge loan financing - 250,000 Repayments of bridge financing - (500,000) Issuance of common stock, net 439,203 1,806,404 Net cash provided by financing activities 439,203 1,556,404 NET INCREASE (DECREASE) IN CASH 223,503 1,379,885 CASH AND CASH EQUIVALENTS, BEGINNING OF THE PERIOD 2,245,858 76,147 CASH AND CASH EQUIVALENTS, END OF THE PERIOD $2,469,361 $1,456,032 DATASOURCE: XELR8 Holdings, Inc. CONTACT: John Pougnet, CEO, XELR8 Holdings, Inc., +1-303-316-8577, ; or Stephen D. Axelrod, CFA, , or Media, Alisa Steinberg, , both of Wolfe Axelrod Weinberger Assoc. LLC, +1-212-370-4500, for XELR8 Holdings, Inc. Web site: http://www.xelr8.com/ http://www.drinkbazi.com/

Copyright